MLPHMolecular Pharmacology (USA), Ltd.

About Molecular Pharmacology (USA), Ltd. (MLPH)

Molecular Pharmacology (USA), Ltd. (MLPH) is a N/A company headquartered in East Stroudsburg, PA, United States whose shares trade over-the-counter on the Pink tier.

Molecular Pharmacology (USA) Limited, (MPL-USA) is a public, biotechnology company. In the past, it dedicated to the discovery and development of analgesic and anti-inflammatory products based on the proprietary MPL-TL (tripeptofen) compound. Currently, it is a shell. with an intent of engaging in some areas in life sciences.

Products and services

Prior to 2014, the comapny had been in pharmacology research. Currently it's a shell.

MLPH key facts

Ticker symbol

MLPH

Market tier

Pink

Headquarters

East Stroudsburg, PA, United States

Country of incorporation

US

Year of incorporation

2002

Employees

1

Estimated market cap

$100.0K (as of May 13, 2025)

Shares outstanding

999,553,740

Reporting standard

Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

12/31

Latest filing

Quarterly Report (Mar 31, 2025)

Molecular Pharmacology (USA), Ltd. leadership

• Xin Shi — CEO, President, Secretary
• Harry Haining Zhang — Consultant

Explore more: Pink stocks · OTC stocks starting with M